相似文献
1
Pericytes from human veins for treatment of myocardial ischemia.
Trends Cardiovasc Med. 2013 Apr;23(3):66-70. doi: 10.1016/j.tcm.2012.09.002. Epub 2013 Jan 10.
2
Combined intramyocardial delivery of human pericytes and cardiac stem cells additively improves the healing of mouse infarcted hearts through stimulation of vascular and muscular repair.
Circ Res. 2015 May 8;116(10):e81-94. doi: 10.1161/CIRCRESAHA.115.306146. Epub 2015 Mar 23.
3
Human pericytes for ischemic heart repair.
Stem Cells. 2013 Feb;31(2):305-16. doi: 10.1002/stem.1285.
4
Discovering cardiac pericyte biology: From physiopathological mechanisms to potential therapeutic applications in ischemic heart disease.
Vascul Pharmacol. 2016 Nov;86:53-63. doi: 10.1016/j.vph.2016.05.009. Epub 2016 Jun 5.
5
Transplantation of Allogeneic Pericytes Improves Myocardial Vascularization and Reduces Interstitial Fibrosis in a Swine Model of Reperfused Acute Myocardial Infarction.
J Am Heart Assoc. 2018 Jan 22;7(2):e006727. doi: 10.1161/JAHA.117.006727.
6
Transplantation of Purified Human Pericytes for Myocardial Repair in SCID-hu Mice.
Methods Mol Biol. 2021;2235:13-26. doi: 10.1007/978-1-0716-1056-5_2.
7
miR-19a-3p containing exosomes improve function of ischaemic myocardium upon shock wave therapy.
Cardiovasc Res. 2020 May 1;116(6):1226-1236. doi: 10.1093/cvr/cvz209.
8
Transplantation of human pericyte progenitor cells improves the repair of infarcted heart through activation of an angiogenic program involving micro-RNA-132.
Circ Res. 2011 Sep 30;109(8):894-906. doi: 10.1161/CIRCRESAHA.111.251546. Epub 2011 Aug 25.
9
Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function.
Nat Med. 2001 Apr;7(4):430-6. doi: 10.1038/86498.
10
Injectable shear-thinning hydrogels used to deliver endothelial progenitor cells, enhance cell engraftment, and improve ischemic myocardium.
J Thorac Cardiovasc Surg. 2015 Nov;150(5):1268-76. doi: 10.1016/j.jtcvs.2015.07.035. Epub 2015 Jul 17.
引用本文的文献
1
Vasa Vasorum in Saphenous Vein for CABG: A Review of Morphological Characteristics.
Braz J Cardiovasc Surg. 2023 Oct 5;38(6):e20230045. doi: 10.21470/1678-9741-2023-0045.
2
Immune Cells in the BBB Disruption After Acute Ischemic Stroke: Targets for Immune Therapy?
Front Immunol. 2021 Jun 23;12:678744. doi: 10.3389/fimmu.2021.678744. eCollection 2021.
3
Emerging Role of Pericytes and Their Secretome in the Heart.
Cells. 2021 Mar 4;10(3):548. doi: 10.3390/cells10030548.
4
Fabrication of New Hybrid Scaffolds for Perivascular Application to Treat Limb Ischemia.
Front Cardiovasc Med. 2020 Nov 19;7:598890. doi: 10.3389/fcvm.2020.598890. eCollection 2020.
5
COVID-19 - Endothelial Axis and Coronary Artery Bypass Graft Patency: a Target for Therapeutic Intervention?
Braz J Cardiovasc Surg. 2020 Oct 1;35(5):757-763. doi: 10.21470/1678-9741-2020-0303.
6
Relative contributions of adipose-resident CD146 pericytes and CD34 adventitial progenitor cells in bone tissue engineering.
NPJ Regen Med. 2019 Jan 7;4:1. doi: 10.1038/s41536-018-0063-2. eCollection 2019.
7
Regenerating the Cardiovascular System Through Cell Reprogramming; Current Approaches and a Look Into the Future.
Front Cardiovasc Med. 2018 Aug 20;5:109. doi: 10.3389/fcvm.2018.00109. eCollection 2018.
8
Pericytes in Brain Injury and Repair After Ischemic Stroke.
Transl Stroke Res. 2017 Apr;8(2):107-121. doi: 10.1007/s12975-016-0504-4. Epub 2016 Nov 12.
9
Pericyte Seeded Dual Peptide Scaffold with Improved Endothelialization for Vascular Graft Tissue Engineering.
Adv Healthc Mater. 2016 Dec;5(23):3046-3055. doi: 10.1002/adhm.201600699. Epub 2016 Oct 26.
10
Prospective purification of perivascular presumptive mesenchymal stem cells from human adipose tissue: process optimization and cell population metrics across a large cohort of diverse demographics.
Stem Cell Res Ther. 2016 Mar 30;7:47. doi: 10.1186/s13287-016-0302-7.
本文引用的文献
1
Small RNA sequencing reveals microRNAs that modulate angiotensin II effects in vascular smooth muscle cells.
J Biol Chem. 2012 May 4;287(19):15672-83. doi: 10.1074/jbc.M111.322669. Epub 2012 Mar 19.
2
CD34-positive stem cells: in the treatment of heart and vascular disease in human beings.
Tex Heart Inst J. 2011;38(5):474-85.
3
Effect of hypoxia-inducible factor-1alpha gene therapy on walking performance in patients with intermittent claudication.
Circulation. 2011 Oct 18;124(16):1765-73. doi: 10.1161/CIRCULATIONAHA.110.009407. Epub 2011 Sep 26.
4
Transplantation of human pericyte progenitor cells improves the repair of infarcted heart through activation of an angiogenic program involving micro-RNA-132.
Circ Res. 2011 Sep 30;109(8):894-906. doi: 10.1161/CIRCRESAHA.111.251546. Epub 2011 Aug 25.
5
Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia.
Lancet. 2011 Jun 4;377(9781):1929-37. doi: 10.1016/S0140-6736(11)60394-2. Epub 2011 May 28.
6
Bone marrow-derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair.
Cell Stem Cell. 2011 Apr 8;8(4):389-98. doi: 10.1016/j.stem.2011.02.002.
7
MicroRNA-132-mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis.
Nat Med. 2010 Aug;16(8):909-14. doi: 10.1038/nm.2186. Epub 2010 Aug 1.
8
Perivascular ancestors of adult multipotent stem cells.
Arterioscler Thromb Vasc Biol. 2010 Jun;30(6):1104-9. doi: 10.1161/ATVBAHA.109.191643. Epub 2010 May 7.
9
Human adult vena saphena contains perivascular progenitor cells endowed with clonogenic and proangiogenic potential.
Circulation. 2010 Apr 20;121(15):1735-45. doi: 10.1161/CIRCULATIONAHA.109.899252. Epub 2010 Apr 5.
10
Enhancing the outcome of cell therapy for cardiac repair: progress from bench to bedside and back.
Circulation. 2010 Jan 19;121(2):325-35. doi: 10.1161/CIRCULATIONAHA.109.901405.
Zotero 插件